Cardiome Pharma

Contact
cardiome.com
+1-604-677-6905

Cardiome Pharma Corp.

6190 Agronomy Rd., 6th Floor
V6T 1Z3 Vancouver
Canada
+1-604-677-6905
cardiome.com
Contact
Profile News
Contact

About Cardiome Pharma

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two late-stage clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), a Phase 1 program for GED-aPC, an engineered analog of recombinant human activated Protein C, and a pre-clinical program directed at improving cardiovascular function.

Read more about Cardiome Pharma
Facts about Cardiome Pharma
  • Focus : Manufacturer
  • Industry : Pharma

News about Cardiome Pharma

Cardiome Pharma

14-Apr-2009 | business & finance

Merck & Co., Inc. and Cardiome Sign License Agreement for Vernakalant

Merck & Co., Inc. and Cardiome Pharma Corp. announced a collaboration and license agreement for the development and commercialization of vernakalant, an ...

Read news
Cardiome Pharma

13-Aug-2008 | research and development

Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)

Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated ...

Read news
Cardiome Pharma

19-Mar-2008 | research and development

Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant

Cardiome Pharma Corp. announced positive interim clinical results from its 90-day Phase 2b study of vernakalant (oral). The interim analysis demonstrated ...

Read news
Cardiome Pharma

26-Oct-2005 | business & finance

Cardiome Acquires Artesian Therapeutics

Cardiome Pharma Corp. announced that it has completed the acquisition of Artesian Therapeutics, Inc., further to the letter of intent ("LOI") announced on ...

Read news
Cardiome Pharma

31-Aug-2005 | business & finance

Cardiome Announces Letter Of Intent To Acquire Artesian Therapeutics

Cardiome Pharma Corp. announced that it has executed a letter of intent ("LOI") to acquire Artesian Therapeutics, Inc., a privately held U.S. biopharmaceuti ...

Read news
Cardiome Pharma

08-Feb-2005 | research and development

Cardiome Reports Additional ACT 1 Clinical Results

Cardiome Pharma Corp and its co-development partner Fujisawa Healthcare, Inc. announced additional results from their recently completed 416-patient atrial ...

Read news
Show more news about Cardiome Pharma

Here you will find Cardiome Pharma Corp.